PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1)

Date

2019-01-01

Author

Seza, Esin Gülce
Güderer, İsmail
Ermis, Çagdas
Banerjee, Sreeparna

Metadata

Show full item record

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Item Usage Stats

124
views

0
downloads

© 2019 Atlas of Genetics and Cytogenetics in Oncology and Haematology.Protein kinase AMP-activated catalytic subunit alpha 1 (PRKAA1), also known as AMPK α1, is an energy sensor that plays a key role in the regulation of cellular energy metabolism. AMPK α1 is the catalytic subunit of the heterotrimeric AMPK protein with a length of 548 amino acids. A key switch to activate this protein is an alteration in the AMP/ATP ratio. The protein is dysregulated in several human diseases including diabetes and metabolic syndrome, cardiovascular diseases, neurodegenerative diseases and many cancer types (Steinberg and Kemp, 2009). Two isoforms of AMPK exist including AMPK α1 and AMPK α2; however, discrimination between these isoforms for their involvement in certain diseases is currently not possible.

URI

https://hdl.handle.net/11511/69602

Journal

Atlas of Genetics and Cytogenetics in Oncology and Haematology

DOI

https://doi.org/10.4267/2042/70205

Collections

Department of Biology, Article

Suggestions

OpenMETU
Core

TrkA in vivo function is negatively regulated by ubiquitination. Kiriş, Erkan; Yanpallewar, S; Dorsey, SG; Becker, J; Bavari, S; Palko, ME; Coppola, V; Tessarollo, L (2014-03-12) TrkA is a tyrosine kinase receptor required for development and survival of the peripheral nervous system. In the adult, TrkA and its ligand NGF are peripheral pain mediators, particularly in inflammatory pain states. However, how TrkA regulates the function of nociceptive neurons and whether its activity levels may lead to sensory abnormalities is still unclear. Here we report the characterization of a 3 aa (KFG) domain that negatively regulates TrkA level and function in response to NGF. Deletion of this ...
Missense Genetic Polymorphisms of Microsomal (EPHX1) and Soluble Epoxide Hydrolase (EPHX2) and Their Relation to the Risk of Large Artery Atherosclerotic Ischemic Stroke in a Turkish Population Demirdogen, Birsen Can; Micoogullari, Yagmur; Ozcelik, Aysun Turkanoglu; Adalı, Orhan (2020-01-01) Purpose: Soluble epoxide hydrolase (sEH) and microsomal epoxide hydrolase (mEH) both catalyze the metabolism of epoxyeicosatrienoic acids (EETs), lipid signaling molecules that are protective against ischemic brain injury owing to their participation in the regulation of vascular tone and cerebral blood flow. In addition, mEH metabolizes polycyclic aromatic hydrocarbons, one of the causative factors of atherosclerotic lesion development. In this study, we aimed to investigate the association of enzyme activ...
Exact and Approximate Stochastic Simulations of the MAPK Pathway and Comparisons of Simulations' Results Purutçuoğlu Gazi, Vilda (2006-10-01) The MAPK (mitogen-activated protein kinase) or its synonymous ERK (extracellular signal regulated kinase) pathway whose components are Ras, Raf, and MEK proteins with many biochemical links, is one of the major signalling systems involved in cellular growth control of eukaryotes including cell proliferation, transformation, differentiation, and apoptosis. In this study we describe the MAPK/ERK pathway via (quasi) biochemical reactions and then implement the pathway by a stochastic Markov process. A novelty ...
Causes and consequences of seasonal variation of phosphoglucomutase (pgm) enzyme polymorphism in honeybees, (apis mellifera l.) of turkey Güldüren, Zerrin; Kence, Meral; Department of Biology (2008) Phosphoglucomutase (PGM) is one of the central enzymes in energy metabolism at a branch point at the head of the metabolic pathway leading into glycogen metabolism, pentose shunt and the main glycolytic cycle, catalyzing the reversible interconversion of glucose-1-phosphate to glucose-6-phosphate. Whole year, month to month analysis of pattern of allozyme variation at Pgm and Hk loci in Apis mellifera L. from three provinces; Kırklareli, Artvin, and Hatay revealed that there is significant seasonal variatio...
Nicotine is a Selective Pharmacological Chaperone of Acetylcholine Receptor Number and Stoichiometry. Implications for Drug Discovery Lester, Henry A.; Xiao, Cheng; Srinivasan, Rahul; Son, Çağdaş Devrim; Miwa, Julie; Pantoja, Rigo; Banghart, Matthew R.; Dougherty, Dennis A.; Goate, Alison M.; Wang, Jen C. (2009-03-01) The acronym SePhaChARNS, for "selective pharmacological chaperoning of acetylcholine receptor number and stoichiometry," is introduced. We hypothesize that SePhaChARNS underlies classical observations that chronic exposure to nicotine causes "upregulation" of nicotinic receptors (nAChRs). If the hypothesis is proven, (1) SePhaChARNS is the molecular mechanism of the first step in neuroadaptation to chronic nicotine; and (2) nicotine addiction is partially a disease of excessive chaperoning. The chaperone is...

Citation Formats

E. G. Seza, İ. Güderer, Ç. Ermis, and S. Banerjee, “PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1),” Atlas of Genetics and Cytogenetics in Oncology and Haematology, pp. 105–111, 2019, Accessed: 00, 2020. [Online]. Available: https://hdl.handle.net/11511/69602.